Govindram Seksaria Institute of Dacryology, L.V. Prasad Eye Institute, Hyderabad, India.
Eye (Lond). 2021 Jun;35(6):1600-1604. doi: 10.1038/s41433-020-01125-1. Epub 2020 Aug 10.
To assess the exclusive role and outcomes of Crigler's lacrimal sac compression in the management of congenital nasolacrimal duct obstruction (CNLDO).
Retrospective interventional case-series was performed on patients diagnosed with CNLDO and who were advised Crigler's lacrimal sac compression (CLSC) at a tertiary care Dacryology Institute from Jan 2016 to June 2019. CNLDO patients who were practicing incorrect techniques of lacrimal sac compression at presentation were separately assessed. All the patients were assigned to four groups (Gr 1: 0-3 months, Gr 2: >3 & <6 months, Gr 3: >6 & <9 months and Gr 4: >9 and <12 months) based on the age at which the CLSC was initiated and followed up quarterly or as needed till at least 1 year of age. The parameters studied include patient demographics, clinical presentation, age of initiation of CLSC, success rate with CLSC, and need for additional interventions. Success was defined as the subjective resolution of epiphora and discharge with objective measures of normal tear meniscus height and dye clearance on fluorescein dye disappearance test.
A total number of 1240 patients with CNLDO were assessed. Of these, 1037 patients were advised correct techniques of CLSC from the beginning, and the remaining 203 patients were referred but performing it incorrectly at presentation. Of the 1037 patients, 236 were lost to follow-up; hence, a total of 1004 patients (801 + 203) were included for final analysis. CLSC was found to be an effective conservative strategy in the management of CNLDO. The rate of resolution of CNLDO in Gr 1 to Gr 4 was 87.3%, 78.9%, 77.9%, and 76.8%, respectively. There were no statistically significant differences in the outcomes based on the age of CLSC initiation. The referred patients whose techniques were rectified following the initial incorrect techniques showed a resolution of 61.2% (79/129). The correct techniques of CLSC appeared to influence the outcomes. However, the age of its initiation did not substantially impact the outcomes. Significantly high resolution was noted even beyond nine months of age and encouraging results beyond 12 months of age.
It is crucial to initiate the correct techniques of Crigler's lacrimal sac compression to achieve favourable outcomes. Age of initiation of CLSC in infancy does not appear to influence the outcomes. The resolution rate continued to be significantly high up to 1 year of age. There is a need to assess the role of CLSC beyond 12 months of age.
评估克里格勒氏泪囊压迫术在先天性鼻泪管阻塞(CNLDO)治疗中的独特作用和结果。
对 2016 年 1 月至 2019 年 6 月在一家三级眼科泪道研究所被诊断为 CNLDO 并接受克里格勒氏泪囊压迫术(CLSC)建议的患者进行回顾性介入病例系列研究。分别评估在就诊时采用不正确泪囊压迫技术的 CNLDO 患者。所有患者均根据 CLSC 开始的年龄分为四组(Gr 1:0-3 个月,Gr 2:>3 岁且<6 个月,Gr 3:>6 岁且<9 个月,Gr 4:>9 岁且<12 个月),并每季度或根据需要进行随访,直到至少 1 岁。研究的参数包括患者人口统计学、临床表现、CLSC 开始年龄、CLSC 成功率以及是否需要额外干预。成功定义为主观上消除溢泪和分泌物,同时客观上泪膜高度正常,荧光素染料消失试验中染料清除。
共评估了 1240 例 CNLDO 患者。其中,1037 例患者从一开始就接受了正确的 CLSC 技术建议,其余 203 例患者被转介但在就诊时采用了不正确的技术。在 1037 例患者中,236 例失访;因此,共有 1004 例(801+203)患者最终纳入分析。CLSC 是治疗 CNLDO 的一种有效保守策略。Gr 1 至 Gr 4 的 CNLDO 缓解率分别为 87.3%、78.9%、77.9%和 76.8%。根据 CLSC 开始年龄,结果无统计学差异。在初始不正确技术后纠正技术的转诊患者的缓解率为 61.2%(79/129)。正确的 CLSC 技术似乎影响了结果。然而,其开始年龄并没有对结果产生实质性影响。即使在九个月以上的年龄也能显著提高缓解率,并在 12 个月以上的年龄获得令人鼓舞的结果。
必须采用正确的克里格勒氏泪囊压迫术技术才能获得良好的结果。婴儿期 CLSC 的开始年龄似乎不会影响结果。缓解率在 1 岁时仍显著较高。有必要评估 12 个月以上的 CLSC 作用。